SonoVascular develops a multi-mechanistic thrombectomy system for the treatment of arterial and venous diseases.
SonoVascular has raised $6.0M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
SonoVascular is headquartered in Chapel Hill, United States.
SonoVascular develops a multi-mechanistic thrombectomy system for the treatment of arterial and venous diseases.
SonoVascular is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SonoVascular — Funding & Investors." VCBacked, February 3, 2026, https://www.vcbacked.co/company/sonovascular. Accessed July 25, 2026.
VCBacked. (2026). SonoVascular — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/sonovascular
{{cite web |title=SonoVascular — Funding & Investors |url=https://www.vcbacked.co/company/sonovascular |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated